APO Research
Talk to an analyst

APO RESEARCH · REPORT

10-Valent Pneumococcal Polysaccharide Vaccine

10-Valent Pneumococcal Polysaccharide Vaccine is a vaccine product category defined by its pneumococcal antigen composition and formulation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antigen composition, conjugation status, presentation and labelled indications distinguish supplied vaccines. Products with different compositions are not interchangeable solely because a headline count is similar.

The commercial boundary

The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.

Which antigen composition and formulation define the vaccine?

Antigen composition, conjugation status, presentation and labelled indications distinguish supplied vaccines. Products with different compositions are not interchangeable solely because a headline count is similar.

Selected research

Market Analysis & Forecast

Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry Research10-Valent Pneumococcal Polysaccharide Vaccine Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal 10-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global 10-Valent Pneumococcal Polysaccharide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for 10-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for 10-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for 10-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for 10-Valent Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine include GSK. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for 10-Valent Pneumococcal Polysaccharide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of 10-Valent Pneumococcal Polysaccharide Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for 10-Valent Pneumococcal Polysaccharide Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the 10-Valent Pneumococcal Polysaccharide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global 10-Valent Pneumococcal Polysaccharide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for 10-Valent Pneumococcal Polysaccharide Vaccine sales, projected growth trends, production technology, application and end-user industry.

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Company

GSK

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-filled Syringe

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Application

Hospital

Clinic

10-Valent Pneumococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Valent Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 10-Valent Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Valent Pneumococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of 10-Valent Pneumococcal Polysaccharide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of 10-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 10-Valent Pneumococcal Polysaccharide Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Dose Vial Major Manufacturers Table 3. Pre-filled Syringe Major Manufacturers Table 4. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Trends Table 8. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers Table 9. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges Table 10. 10-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints Table 11. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2026) Table 20. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2027-2032) Table 21. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global 10-Valent Pneumococcal Polysaccharide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global 10-Valent Pneumococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers, Product Type & Application Table 29. Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global 10-Valent Pneumococcal Polysaccharide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2026) Table 41. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2027-2032) Table 42. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2026) Table 53. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2027-2032) Table 54. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio Table 60. GSK Recent Development Table 61. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 62. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 63. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 64. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 65. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 66. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 67. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 68. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 69. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 70. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 71. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 72. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 73. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 77. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 78. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 79. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 80. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 81. United States 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 82. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 83. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 84. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 87. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 88. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 89. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 90. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 93. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 94. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 95. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 96. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 100. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 101. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 102. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 103. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 104. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 105. France 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 106. U.K. 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 107. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 108. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 109. Spain 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 110. Netherlands 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 111. Switzerland 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 112. Sweden 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 113. Poland 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 114. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 115. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 116. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 117. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 118. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 119. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 120. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 121. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 122. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 123. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 124. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 125. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 126. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 129. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 130. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 131. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 132. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 135. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 136. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 137. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 138. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 143. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 144. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 145. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 146. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 147. South Korea 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 148. India 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 149. Australia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 150. Taiwan 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 152. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (k units) Table 155. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (k units) Table 156. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 157. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 158. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (k units) Table 161. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (k units) Table 162. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 163. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 164. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (k units) Table 169. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2027-2032) & (k units) Table 170. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 171. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 172. Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 173. Argentina 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 174. Chile 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 175. Colombia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 176. Peru 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 178. Israel 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 179. UAE 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Iran 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Egypt 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. 10-Valent Pneumococcal Polysaccharide Vaccine Distributors List Table 186. 10-Valent Pneumococcal Polysaccharide Vaccine Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. 10-Valent Pneumococcal Polysaccharide Vaccine Image Figure 2. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Dose Vial Image Figure 5. Pre-filled Syringe Image Figure 6. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (2021-2032) & (k units) Figure 16. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) 10-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 39. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 40. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 41. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 42. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 43. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 44. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 46. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 48. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 50. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 51. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 52. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 53. China 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 54. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 56. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 58. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2021-2032) Figure 66. 10-Valent Pneumococcal Polysaccharide Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. 10-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-filled Syringe
Applications
  • Hospital
  • Clinic
Companies covered
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 10-Valent Pneumococcal Polysaccharide Vaccine Market by Type
  3. 1.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Dose Vial
  5. 1.2.3 Pre-filled Syringe
  6. 1.3 10-Valent Pneumococcal Polysaccharide Vaccine Market by Application
  7. 1.3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 10-Valent Pneumococcal Polysaccharide Vaccine Market Dynamics
  1. 2.1 10-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
  2. 2.2 10-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers
  3. 2.3 10-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 10-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
  3. 3.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
  9. 3.4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
  2. 4.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
  6. 4.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
  16. 4.8.2 2025 10-Valent Pneumococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
5 10-Valent Pneumococcal Polysaccharide Vaccine Market by Type
  1. 5.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type
  2. 5.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
  6. 5.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type
6 10-Valent Pneumococcal Polysaccharide Vaccine Market by Application
  1. 6.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
  2. 6.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
  6. 6.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
  6. 7.1.5 GSK Recent Developments
8 North America
  1. 8.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 8.1.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 8.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 8.2.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 8.3 North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  10. 8.3.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America 10-Valent Pneumococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 9.1.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 9.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 9.2.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 9.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  10. 9.3.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 10.1.1 China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 10.2 China 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 10.2.1 China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 11.1.1 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 11.2 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 11.2.1 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 11.3 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  10. 11.3.1 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia 10-Valent Pneumococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
  2. 12.1.1 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 12.2.1 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  10. 12.3.1 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA 10-Valent Pneumococcal Polysaccharide Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 10-Valent Pneumococcal Polysaccharide Vaccine Value Chain Analysis
  2. 13.1.1 10-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 10-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
  6. 13.2 10-Valent Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 10-Valent Pneumococcal Polysaccharide Vaccine Distributors
  9. 13.2.3 10-Valent Pneumococcal Polysaccharide Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst